Last update 01 Nov 2024

Kaibos (Shanghai) Biopharmaceutical Co., Ltd.

Private Company|
2021|
Shanghai Shi, China

Overview

Related

2
Drugs associated with Kaibos (Shanghai) Biopharmaceutical Co., Ltd.
Mecbotamab vedotin
Target
AXL x Tubulin
Mechanism
AXL inhibitors [+1]
Active Org.
Kaibos (Shanghai) Biopharmaceutical Co., Ltd. [+2]
Originator Org.
BioAtla, Inc.BioAtla, Inc.
Active Indication
metastatic non-small cell lung cancer [+4]
Inactive Indication
Ovarian Cancer [+1]
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
Ozuriftamab vedotin
Target
ROR2 x Tubulin
Mechanism
ROR2 inhibitors [+1]
Active Org.
BioAtla, Inc.BioAtla, Inc. [+2]
Originator Org.
BioAtla, Inc.BioAtla, Inc.
Active Indication
Recurrent Squamous Cell Carcinoma of the Head and Neck [+6]
Inactive Indication
Ovarian Cancer
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Kaibos (Shanghai) Biopharmaceutical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Kaibos (Shanghai) Biopharmaceutical Co., Ltd.
Login to view more data
100 Deals associated with Kaibos (Shanghai) Biopharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Kaibos (Shanghai) Biopharmaceutical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Ozuriftamab vedotin
 ( ROR2 x Tubulin )		Melanoma
More
IND Approval
Mecbotamab vedotin
 ( AXL x Tubulin )		Sarcoma
More
IND Approval
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free